ARDS following FOLFIRI/irinotecan treatment of recurrent esophageal cancer

Authors :: Manuel G. Cosio
Kim Lokar Oliani
Marina Saetta
Paolo Spagnolo
Matteo Bonato
Source :: Minerva Respiratory Medicine. 60
Publication Year :: 2021
Publisher :: Edizioni Minerva Medica, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Irinotecan
medicine.medical_specialty
ARDS
business.industry
Internal medicine
medicine
FOLFIRI
business
Recurrent esophageal cancer
medicine.disease
Gastroenterology
medicine.drug

Full Text Access

Tools